We are seeking a highly talented, innovative, and motivated Scientist to join our Pre-clinical Research Group in AgenTus Therapeutics. The selected candidate will work as part of an integrated research team focused on discovering and validating novel immunotherapeutics.
The successful candidate is expected to work independently to design, execute, and interpret experiments. These experiments will contribute to the team's effort to create more potent immunotherapies, with emphasis on cell therapies. The candidate is expected to be a visible and vital member of a highly collaborative research environment within Agenus and with our internal and external partners. The candidate will have strong supervisory expertise and contribute to program development and prioritization.
AgenTus Therapeutics is a biopharmaceutical company, and subsidiary of Agenus Inc, focusing on the discovery, development, and commercialization of breakthrough “living drugs” to advance cures for cancer patients. AgenTus employs naturally-derived and engineered receptors, specifically T Cell Receptors (TCRs) and Chimeric Antigen Receptors (CARs), designed to supercharge human immune effector cells to seek and destroy cancer. AgenTus will also aim to advance adoptive cell therapy formats which would enable off-the-shelf living drugs.
The incumbent will be expected to design, execute and analyze complex studies and provide leadership within the program. Primary responsibility will involve expansion and characterization of primary human T cells directed against neo-antigens. The incumbent will also be responsible for delivering immunobiology guidance to the cell therapy Discovery Group and assist in assay development and platform support. This will require broad knowledge of current concepts in cancer immunology and associated areas. The individual will present research findings to the cell therapy group and share expertise with other scientists and must be willing to travel to our site based in Boston, USA.
Technical skills to include: